IP Library Granted Patent US 10,034,967
Granted Patent B2
US 10,034,967 · App. 15/219,133 · Granted Jul 31, 2018

Implantable biomaterials having engineered functional surfaces

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,034,967
App. No.
15/219,133
Granted
Jul 31, 2018
Kind
B2
Abstract

Implantable materials having defined patterns of affinity regions for binding endothelial cells and providing for directed endothelial cell migration across the surface of the material. The affinity regions include photochemically altered regions of a material surface and physical members patterned on the material surface that exhibit a greater affinity for endothelial cell binding and migration than the remaining regions of the material surface.

Claims (8)

1. An implantable biomaterial having at least one surface thereof that comprises the biomaterial and a defined pattern of a plurality of functional features having a height above the at least one surface greater than 0μ, each of the plurality of functional features having a greater endothelial cell binding affinity greater than an endothelial cell binding affinity of the biomaterial.

2. The implantable biomaterial according to claim 1 , wherein each of the plurality of functional features further comprises a titanium oxide layer.

3. The implantable biomaterial according to claim 1 , wherein the biomaterial is made of a material that comprises a nickel-titanium alloy.

4. The implantable biomaterial according to claim 1 , wherein each of the plurality of functional features is made of a material that comprises carbon.

5. The implantable biomaterial according to claim 1 , wherein the functional features have a height between greater than 0μ to about 3.0μ.

6. The implantable biomaterial according to claim 1 , wherein each of the functional features comprises a focal adhesion point for affinity binding of endothelial cells.

7. The implantable biomaterial according to claim 1 , wherein each of the functional features has a width between about 10 μm to about 75 μm.

8. The implantable biomaterial according to claim 1 , further comprising a gap distance between adjacent functional features between about 10 μm to about 75 μm.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 22, 2018
From: VACTRONIX SCIENTIFIC, INC.
To: VACTRONIX SCIENTIFIC, LLC
Reel/Frame 046203/0682 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2018
From: ADVANCED BIO PROSTHETIC SURFACES, LTD., A WHOLLY OWNED SUBSIDIARY OF PALMAZ SCIENTIFIC, INC.
To: VACTRONIX SCIENTIFIC, INC.
Reel/Frame 045709/0763 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 25, 2016
From: PALMAZ, JULIO C.; SPRAGUE, EUGENE A.
To: ADVANCED BIO PROSTHETIC SURFACES, LTD., A WHOLLY OWNED SUBSIDIARY OF PALMAZ SCIENTIFIC, INC.
Reel/Frame 039249/0321 →